Department of Oncology, Orebro University Hospital, Orebro, Sweden.
Head Neck. 2010 Aug;32(8):1062-8. doi: 10.1002/hed.21292.
The aims of this study were to analyze how age affects treatment and treatment outcome, and to determine whether tumor characteristics differ between different age groups with laryngeal cancer.
Patients with laryngeal cancer during 1978-2004 in the Uppsala-Orebro region in Sweden were retrospectively studied.
There were no significant differences in the 945 cases between age groups concerning major patient and tumor characteristics, such as male/female ratio, distribution of glottic/supraglottic tumors, stage, or site of recurrence. Overall survival (OS) and disease-specific survival (DSS) were worse among the oldest, although a significant proportion was cured. Relapse risk was lower among the oldest (12%) compared with the youngest (23%). The risk of never becoming tumor-free was 25% among the oldest and 7% in the youngest. Among the most elderly, only 1 late recurrence occurred.
Elderly patients with laryngeal carcinoma cope well with treatment. Undertreatment may determine outcome more than age. The oldest group should be followed for a minimum of 2 years.
本研究旨在分析年龄如何影响治疗和治疗效果,并确定喉癌不同年龄组之间的肿瘤特征是否存在差异。
对瑞典乌普萨拉-厄勒布鲁地区 1978-2004 年间的喉癌患者进行回顾性研究。
945 例患者在年龄组之间,主要患者和肿瘤特征(如男女比例、声门/声门上肿瘤分布、分期或复发部位)无显著差异。尽管有相当一部分患者得到了治愈,但最年长组的总体生存率(OS)和疾病特异性生存率(DSS)较差。与最年轻组(23%)相比,最年长组的复发风险较低(12%)。最年长组中从未无肿瘤的风险为 25%,而最年轻组为 7%。在最年长的患者中,仅发生 1 例晚期复发。
老年喉癌患者对治疗的耐受性良好。治疗不足可能比年龄更能决定预后。最年长的患者应至少随访 2 年。